Pergolide protects dopaminergic neurons in primary culture under stress conditions

Early Treatment of Parkinson??s Disease with Cabergoline Delays the Onset of Motor Complications

U. K. Rinne, F. Bracco, C Chouza et al. · Drugs · 1998 · 325 citations

Medicine, Neurology, Pharmacology +15

Dopaminergic cell death induced by MPP⁺, oxidant and specific neurotoxicants shares the common molecular mechanism

Hong Sung Chun, Gary E. Gibson, Lorraine A. DeGiorgio et al. · Journal of Neurochemistry · 2001 · 260 citations · Full text

Life Sciences, Neuroscience, Toxicology +17

Toxic and Protective Effects of <scp>l</scp>‐DOPA on Mesencephalic Cell Cultures

Catherine Mytilineou, Shan‐Kuo Han, Gerald Cohen · Journal of Neurochemistry · 1993 · 243 citations

Life Sciences, Neurobiology, Neuroscience +17

A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease

C. Warren Olanow, Stanley Fahn, Manfred D. Muenter et al. · Movement Disorders · 1994 · 203 citations

Medicine, Pharmacology, Pharmacotherapy +10

Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists

Montford F. Piercey, William E. Hoffmann, Martin Smith et al. · European Journal of Pharmacology · 1996 · 165 citations

Medicine, Neuroscience, Pharmacology +15